 NEW YORK, July 14, 2021 PRNewswire -- Seelos Therapeutics, Inc. Nasdaq: SEEL, a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced it will participate in two investor conferences: the BTIG Virtual Biotechnology Conference on August 9 th and 10th and the Canaccord Growth Conference on August 11 th and 12th. Raj Mehra, Ph.D. 